Thermo Fisher Scientific
Capitalisation boursière
$216.5B
Rang mondial
#71
Sommet historique
$244.9B
2021-12-31
Croissance totale
+0%
depuis 2026
Market Cap Context
- Larger than 81% of the 367 companies we track (globally).
- Equivalent to 0.7% of United States's GDP (2025 data).
- Just above: #70 CrowdStrike Holdings, Inc. ($217.8B)
- Just below: #72 IBM ($215.6B)
- Best year: 2000 (+98%). Worst year: 1998 (-62%).
Thermo Fisher Scientific Financial Breakdown (FY 2025)
Source: Yahoo Finance — TMO annual filings (2025) →$44.6B revenue · $8.1B operating income · $6.7B net income
- ●Operating margin: 18.2% on $44.6B in revenue.
- ●R&D is 3.1% of revenue ($1.4B).
- ●Net income margin: 15.0% — $6.7B in profit.
- ●Free cash flow: $6.3B (14.1% of revenue).
Cost / Operating Expenses
Total operating expenses $36.4B
Total
$36.4B
Capital Expenditures
$1.5B
This fiscal year (near-total AI infrastructure buildout)
Free Cash Flow
$6.3B
Trailing twelve months
Figures rounded from the annual SEC filing. Unaudited. For informational purposes only, not investment advice.
À propos de Thermo Fisher Scientific
Thermo Fisher Scientific Inc. is an American life science and clinical research company. It is a global supplier of analytical instruments, clinical development solutions, specialty diagnostics, laboratory, pharmaceutical and biotechnology services. Based in Waltham, Massachusetts, Thermo Fisher was formed through the merger of Thermo Electron and Fisher Scientific in 2006. Thermo Fisher Scientific has acquired other reagent, consumable, instrumentation, and service providers, including Life Technologies Corporation (2013), Alfa Aesar (2015), Affymetrix (2016), FEI Company (2016), BD Advanced Bioprocessing (2018), and PPD (2021).
Historique de la capitalisation boursière de Thermo Fisher Scientific (2026–2026)
Thermo Fisher Scientific vs Sector Peers by Market Cap
Comparer Thermo Fisher Scientific
Historique du classement
| Année | Capitalisation boursière | Rang | Variation sur un an |
|---|---|---|---|
| 2026 | $216.5B | #71(↓9) | +0.7% |
| 2025 | $215.0B | #62(↓9) | +11.8% |
| 2024 | $192.3B | #53(↓4) | -1.7% |
| 2023 | $195.7B | #49(↓12) | -3.4% |
| 2022 | $202.5B | #37(↓6) | -17.3% |
| 2021 | $244.9B | #31(↑8) | +43.5% |
| 2020 | $170.6B | #39(↑16) | +43.7% |
| 2019 | $118.7B | #55(↑4) | +45.6% |
| 2018 | $81.5B | #59(↑12) | +18.2% |
| 2017 | $69.0B | #71(↑17) | +35.1% |
| 2016 | $51.1B | #88(↓14) | -0.1% |
| 2015 | $51.1B | #74(↑11) | +13.8% |
| 2014 | $44.9B | #85(↓4) | +13.1% |
| 2013 | $39.7B | #81(↑35) | +75.9% |
| 2012 | $22.6B | #116(↑16) | +42.8% |
| 2011 | $15.8B | #132(↓10) | -18.8% |
| 2010 | $19.5B | #122(↓2) | +16.1% |
| 2009 | $16.8B | #120(↓3) | +40.0% |
| 2008 | $12.0B | #117(↓9) | -40.9% |
| 2007 | $20.3B | #108(↑16) | +27.4% |
| 2006 | $15.9B | #124(↑21) | +50.3% |
| 2005 | $10.6B | #145(↓24) | -0.2% |
| 2004 | $10.6B | #121(↓4) | +19.8% |
| 2003 | $8.9B | #117(↓4) | +25.2% |
| 2002 | $7.1B | #113(↓1) | -15.7% |
| 2001 | $8.4B | #112(↓6) | -6.8% |
| 2000 | $9.0B | #106(↑12) | +98.3% |
| 1999 | $4.5B | #118(↓23) | -11.4% |
| 1998 | $5.1B | #95(↓53) | -61.5% |
| 1997 | $13.3B | #42(↓4) | +6.7% |
| 1996 | $12.5B | #38(↓3) | +19.0% |
| 1995 | $10.5B | #35 | +73.8% |
| 1994 | $6.0B | #35 |
Autres entreprises du secteur Santé
FAQ
What is Thermo Fisher Scientific Inc.'s market cap?
Thermo Fisher Scientific Inc. (TMO) has a market capitalization of $216.5B, making it the #71 largest company in the world by market cap.
What was Thermo Fisher Scientific Inc.'s highest market cap?
Thermo Fisher Scientific Inc.'s all-time high market cap was $244.9B, reached in 2021-12-31. Its highest rank was #31 in 2021.
What sector is Thermo Fisher Scientific Inc. in?
Thermo Fisher Scientific Inc. is in the Healthcare sector, specifically the Diagnostics & Research industry. It is based in United States.
How has Thermo Fisher Scientific Inc.'s market cap changed over time?
Thermo Fisher Scientific Inc. has been tracked since 2026. Its market cap has grown by 0% from $216.5B in 2026 to $216.5B today.